Phosphoproteomics identifies new therapies for T-cell acute lymphoblastic leukemia
- Post by: OPL
- March 14, 2022
- Comments off
Our study published Feb. 25 in Nature Communications shows that phosphoproteomic profiling can discover novel targets for therapy for T-ALL and it can guide the design of treatment combination strategies when a single therapy is not sufficient.
The analysis of active proteins gives us a more complete picture of the leukemia and allows for selection of a personalized treatment strategy.
For more information see:
https://www.nature.com/articles/s41467-022-28682-1
Categories: News